MedPath
HSA Approval

AMLESSA TABLETS 4 mg/ 10mg

SIN15728P

AMLESSA TABLETS 4 mg/ 10mg

AMLESSA TABLETS 4 mg/ 10mg

June 27, 2019

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09BB04

perindopril and amlodipine

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Krka, d.d., Novo mesto

Active Ingredients

Perindopril 3.34 mg eqv. to Perindopril tert-Butylamine

4.00 mg

Perindopril

Amlodipine besilate 13.870 mg eqv. to amlodipine

10.00mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMLESSA TABLETS 4 mg/ 10mg - HSA Approval | MedPath